Oh, that evil Big Pharma: GlaxoSmithKlein has developed at great cost, over about two decades, a vaccination that can save many people—particularly children—from contracting malaria. From the Guardian story:
Millions of children’s lives could be saved by a new vaccine shown to halve the risk of malaria in the first large-scale trials across seven African countries. The long-awaited results of the largest-ever malaria vaccine study, involving 15,460 babies and small children, show that it could massively reduce the impact of the much-feared killer disease. Malaria takes nearly 800,000 lives a year – mostly children under five. It damages many more. The vaccine has been in development for two decades – the brainchild of scientists at the UK drug company GlaxoSmithKline, which has promised to sell it at no more than a fraction over cost-price, with the excess being ploughed back into further tropical disease research.
Evil!
Oh, and there is no doubt that animal research was involved in the creation of this vaccine, too. Double evil!
You have a decision to make: double or nothing.
For this week only, a generous supporter has offered to fully match all new and increased donations to First Things up to $60,000.
In other words, your gift of $50 unlocks $100 for First Things, your gift of $100 unlocks $200, and so on, up to a total of $120,000. But if you don’t give, nothing.
So what will it be, dear reader: double, or nothing?
Make your year-end gift go twice as far for First Things by giving now.
